Resamirigene bilparvovec

DB16779InvestigationalGene Therapies

AT132 is under investigation in clinical trial NCT03199469 (Gene Transfer Clinical Study in X-linked Myotubular Myopathy).

Also known as
DNA (synthetic adeno-associated virus 8 vector AT132 human myotubularin cDNA-specifying) · Non-replicating adeno-associated viral vector, serotype 8, expressing human myotubularin gene
Code names
AT-132

Resolves to

What you can answer from here — as of September 25, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Resamirigene bilparvovec, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account